November, 16 2026 Monday 12:52 Hrs
Last update 11-9-2025
  • SENSEX :   82,061.82

  • Commodity broking firm in India469.37( 0.58%) 16-Nov-2026
Positive
Sensex 82063.13 470.68  (0.58) 16-Nov-2026
Previous Day Close 81592.45
Today's High/Low
High Low
  •  
  •  
82311.65 81776.9

Company News Details

Concord Biotech Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
543960
INE338H01029
99.7123352
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CONCORDBIO
41.87
12438.87
EPS(TTM)
Face Value()
Div & Yield %
14.2
1
0.63
 

Concord Biotech Ltd
Concord Biotech's Valthera unit completes US FDA audit with one procedural observation
Sep 18,2026

In a regulatory filing made during market hours today, the company stated that the US FDA had conducted an inspection at its formulation facility located at Unit II, Valthera., Dholka Taluka, Ahmadabad district, Gujarat.

The inspection has been successfully concluded with one minor procedural observation which is not related to GMP. The company will submit a comprehensive response to the observation within the stipulated timeline.

'We do not expect this development to have any material impact on the current business operations or existing supplies from this facility,' Concord Biotech said in a statement.

Concord Biotech is an R&D-driven biopharma company that manufactures Active Pharmaceutical Ingredients (APIs) through fermentation & semi-synthetic processes and finished formulations. It has a presence in more than 70 countries worldwide.

The company had reported 32.84% rise in consolidated net profit to Rs 58.53 crore on a 26.23% increase in revenue to Rs 257.49 crore in Q1 FY27 as compared with Q1 FY26.

The scrip rose 1.36% to currently trade at Rs 1481.95 on the BSE.

Top

Attention Investor:

Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers/Depository Participant.     KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, ,Mutual ).    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.